-
-
-
-
-
-
-
IceCure study shows combined therapy achieves 92% lung cancer survival rate
-
-
-
-
-
-
-
IceCure Medical Ltd (ICCM) Tops Q2 EPS by 18c
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on IceCure Medical Ltd. (ICCM)
-
-
-
-
-
-
-
IceCure Medical Ltd (ICCM) Receives Notice of Allowance in China for Novel Cryogenic Pump for Next-Generation Cryoablation Technology
-
-
-
-
-
-
-
IceCure's (ICCM) ICE3 5-Year Trial Results Published in the Peer Reviewed Annals of Surgical Oncology Journal
-
-
-
-
-
-
-
IceCure Medical Ltd (ICCM) Receives Nasdaq Non-compliance Notice
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

